BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18499466)

  • 1. Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS.
    Rodriguez-Pallares J; Rey P; Parga JA; Muñoz A; Guerra MJ; Labandeira-Garcia JL
    Neurobiol Dis; 2008 Jul; 31(1):58-73. PubMed ID: 18499466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons.
    Rodriguez-Pallares J; Parga JA; Muñoz A; Rey P; Guerra MJ; Labandeira-Garcia JL
    J Neurochem; 2007 Oct; 103(1):145-56. PubMed ID: 17573824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease.
    Joglar B; Rodriguez-Pallares J; Rodriguez-Perez AI; Rey P; Guerra MJ; Labandeira-Garcia JL
    J Neurochem; 2009 Apr; 109(2):656-69. PubMed ID: 19245663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons.
    Rey P; Lopez-Real A; Sanchez-Iglesias S; Muñoz A; Soto-Otero R; Labandeira-Garcia JL
    Neurobiol Aging; 2007 Apr; 28(4):555-67. PubMed ID: 16621167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain angiotensin regulates iron homeostasis in dopaminergic neurons and microglial cells.
    Garrido-Gil P; Rodriguez-Pallares J; Dominguez-Meijide A; Guerra MJ; Labandeira-Garcia JL
    Exp Neurol; 2013 Dec; 250():384-96. PubMed ID: 24184051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson's disease.
    Villar-Cheda B; Rodríguez-Pallares J; Valenzuela R; Muñoz A; Guerra MJ; Baltatu OC; Labandeira-Garcia JL
    Eur J Neurosci; 2010 Nov; 32(10):1695-706. PubMed ID: 20964730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies.
    Xu L; Sheng J; Tang Z; Wu X; Yu Y; Guo H; Shen Y; Zhou C; Paraoan L; Zhou J
    Neurobiol Dis; 2005 Feb; 18(1):152-65. PubMed ID: 15649706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of microglial RhoA/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors.
    Villar-Cheda B; Dominguez-Meijide A; Joglar B; Rodriguez-Perez AI; Guerra MJ; Labandeira-Garcia JL
    Neurobiol Dis; 2012 Aug; 47(2):268-79. PubMed ID: 22542954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II increases differentiation of dopaminergic neurons from mesencephalic precursors via angiotensin type 2 receptors.
    Rodriguez-Pallares J; Quiroz CR; Parga JA; Guerra MJ; Labandeira-Garcia JL
    Eur J Neurosci; 2004 Sep; 20(6):1489-98. PubMed ID: 15355316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prothrombin kringle-2-induced oxidative stress contributes to the death of cortical neurons in vivo and in vitro: role of microglial NADPH oxidase.
    Won SY; Choi SH; Jin BK
    J Neuroimmunol; 2009 Sep; 214(1-2):83-92. PubMed ID: 19660816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration.
    Villar-Cheda B; Valenzuela R; Rodriguez-Perez AI; Guerra MJ; Labandeira-Garcia JL
    Neurobiol Aging; 2012 Jan; 33(1):204.e1-11. PubMed ID: 20888078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of microglial reactive oxygen species production by the organochlorinated pesticide dieldrin.
    Mao H; Fang X; Floyd KM; Polcz JE; Zhang P; Liu B
    Brain Res; 2007 Dec; 1186():267-74. PubMed ID: 17999924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive degeneration of dopamine neurons in 6-hydroxydopamine rat model of Parkinson's disease does not involve activation of caspase-9 and caspase-3.
    Ebert AD; Hann HJ; Bohn MC
    J Neurosci Res; 2008 Feb; 86(2):317-25. PubMed ID: 17787016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglial TNF-α mediates enhancement of dopaminergic degeneration by brain angiotensin.
    Borrajo A; Rodriguez-Perez AI; Diaz-Ruiz C; Guerra MJ; Labandeira-Garcia JL
    Glia; 2014 Jan; 62(1):145-57. PubMed ID: 24272709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease.
    Cheng B; Yang X; An L; Gao B; Liu X; Liu S
    Brain Res; 2009 Aug; 1286():25-31. PubMed ID: 19559687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism.
    Lopez-Real A; Rey P; Soto-Otero R; Mendez-Alvarez E; Labandeira-Garcia JL
    J Neurosci Res; 2005 Sep; 81(6):865-73. PubMed ID: 16015598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease.
    Rodriguez M; Alvarez-Erviti L; Blesa FJ; Rodríguez-Oroz MC; Arina A; Melero I; Ramos LI; Obeso JA
    Neurobiol Dis; 2007 Dec; 28(3):316-25. PubMed ID: 17897835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation.
    Kim YS; Choi DH; Block ML; Lorenzl S; Yang L; Kim YJ; Sugama S; Cho BP; Hwang O; Browne SE; Kim SY; Hong JS; Beal MF; Joh TH
    FASEB J; 2007 Jan; 21(1):179-87. PubMed ID: 17116747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic role of glial cells in Parkinson's disease.
    Teismann P; Tieu K; Cohen O; Choi DK; Wu DC; Marks D; Vila M; Jackson-Lewis V; Przedborski S
    Mov Disord; 2003 Feb; 18(2):121-9. PubMed ID: 12539204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.